Sort
40,608 grants matching “prostate cancer”
An Immune Based Therapeutic Approach for Prostate Cancer
$352,615Esteban Celis · Mayo Clinic Rochester · P50 · FY2010 · CA
Ack1: A Critical Regulator of Hormone-Refractory Prostate Cancer
$352,581Nupam P Mahajan · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2010 · CA
Project 1: Resistance caused by AR pathway reactivation
$352,577Charles L Sawyers · Sloan-Kettering Inst Can Research · U54 · FY2020 · CA
Core B - Animal Core
$352,446Evan Todd Keller · University Of Michigan At Ann Arbor · P01 · FY2023 · CA
Investigation of the landscape of immunosequencing and its clinical relevance through novel immunoinformatic approaches
$352,441Li Zhang · University Of California, San Francisco · R01 · FY2022 · LM
Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer
$352,420Jeremy James Johnson · University Of Illinois At Chicago · R37 · FY2020 · CA
Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer
$352,420Jeremy James Johnson · University Of Illinois At Chicago · R37 · FY2019 · CA
Role of histone demethylase JMJD1A in the DNA damage response of prostate cancer cells
$352,371Jianfei Qi · University Of Maryland Baltimore · R01 · FY2016 · CA
CYCLIN D1 FUNCTION IN PROSTATE CANCER
$352,361Yeshiva University · R01 · FY2001 · CA
Project 2 - Fatty Liver Predisposes to Metastasis: Role of Hepatic Stellate Cells
$352,342Ekihiro Seki · Cedars-Sinai Medical Center · P01 · FY2020 · CA
Elucidating the Role of Trop2 in Prostate Cancer
$352,304Tanya I Stoyanova · University Of California Los Angeles · R37 · FY2023 · CA
Self-assembling protoviral nanoparticles
$352,293Nadya Tarasova · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL
$352,286Izidore S Lossos · University Of Miami School Of Medicine · R01 · FY2023 · CA
Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL
$352,283Izidore S Lossos · University Of Miami School Of Medicine · R01 · FY2022 · CA
Radiotherapy-induced tumor immunity
$352,275Dorthe Schaue · University Of California Los Angeles · R01 · FY2017 · CA
Adaptive resistance to AR inhibitors in hypoxia by GPT1
$352,275Zheng David Qian · Oregon Health & Science University · R01 · FY2023 · CA
Radiotherapy-induced tumor immunity
$352,275Dorthe Schaue · University Of California Los Angeles · R01 · FY2015 · CA
Radiotherapy-induced tumor immunity
$352,275Dorthe Schaue · University Of California Los Angeles · R01 · FY2016 · CA
Pathobiology and Mechanism of Progesterone Resistance in Human Endometrial Cancer
$352,275Sanaz Memarzadeh · University Of California Los Angeles · R01 · FY2016 · CA
Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer
$352,275Leonard Stephen Marks · University Of California Los Angeles · R01 · FY2016 · CA
Radiotherapy-induced tumor immunity
$352,275Dorthe Schaue · University Of California Los Angeles · R01 · FY2018 · CA
Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer
$352,275Leonard Stephen Marks · University Of California Los Angeles · R01 · FY2015 · CA
Pathobiology and Mechanism of Progesterone Resistance in Human Endometrial Cancer
$352,275Sanaz Memarzadeh · University Of California Los Angeles · R01 · FY2017 · CA
Pathobiology and Mechanism of Progesterone Resistance in Human Endometrial Cancer
$352,275Sanaz Memarzadeh · University Of California Los Angeles · R01 · FY2015 · CA
Adaptive resistance to HIF1a inhibition in hypoxia
$352,242Zheng David Qian · Oregon Health & Science University · R01 · FY2016 · CA